Pediakind Pharma Private Limited

Pediakind Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U24230GJ2022PTC134435 Incorporated 02 August 2022 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹1.07 Cr
▲ 34% YoY
Net profit · FY 2025
₹1.43 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹2.37 Lakh
EBITDA margin 2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Pediakind Pharma Private Limited

Data last updated:

Pediakind Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 August 2022.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2022PTC134435. Its GSTIN is 23AANCP1308C1ZX (Madhya Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gajendra Gami and Rakesh Gaami.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat 7 – G Ayodhya Nagar Opp – Sahjivan Society Shanti Nagar Usmanpura, Ahmedabad, Gujarat, India – 380013.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.07 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.43 Lakh (net margin 1.3%) and EBITDA of ₹2.37 Lakh (EBITDA margin 2.2%).

Pediakind Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0062166).

Company details

CIN U24230GJ2022PTC134435
Registration Number 134435
Incorporation Date 02 August 2022
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0062166

Recognitions & Rankings of Pediakind Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-MP-23-0062166

Contact details

Pediakind Pharma Private Limited's registered office is in Ahmedabad, Gujarat.

  • Registered Address
    Flat 7 – G Ayodhya Nagar Opp – Sahjivan Society Shanti Nagar Usmanpura, Ahmedabad, Gujarat, India – 380013
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Pediakind Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pediakind Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pediakind Pharma Private Limited, buy the company report.

Financials of Pediakind Pharma Private Limited

FY 2025 filings available

Pediakind Pharma Private Limited reported revenue of ₹1.07 Cr (up 34% YoY) for FY 2025.

Revenue · FY 2025
₹1.07 Cr ▲ 34%
Net profit · FY 2025
₹1.43 Lakh margin 1.3%
EBITDA · FY 2025
₹2.37 Lakh margin 2.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 34%
EBITDA CAGR growth
1 year
▲ 172%

Revenue rose 34% in the latest year. EBITDA rose 172% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.37 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.43 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin2.2%
Net Profit Margin1.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pediakind Pharma Private Limited, buy the company report.

Board of directors of Pediakind Pharma Private Limited

Pediakind Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rakesh GaamiAdditional Director09 Oct 20233 Years 0 MonthsCurrent
Gajendra GamiDirector09 Mar 20233 Years 7 MonthsCurrent

Peer comparison

Pediakind Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Macwin Pharmaceuticals Private Limited₹1.07 Cr (FY 2024)5.0%Chandigarh, India
Alliswell Biohealth Private Limited₹1.07 Cr (FY 2021)6.0%New Delhi, Delhi, India
Agribee Seeds Private Limited₹1.07 Cr (FY 2024)-48.0%Rajkot, Gujarat, India
Ornate Pharma Pvt Ltd₹1.07 Cr (FY 2025)-47.0%Sanand, Gujarat, India
Chemenz Labs (India) Private Limited₹1.07 Cr (FY 2024)85.0%Mandideep, Madhya Pradesh, India
Pediakind Pharma Private Limitedthis company₹1.07 Cr (FY 2025)₹1.43 Lakh1.3%34.0%Ahmedabad, Gujarat, India
S K Ink Private Limited₹1.07 Cr (FY 2024)-30.0%Vapi, Gujarat, India
Poi India Biotech Private Limited₹1.07 Cr (FY 2025)22.0%Hardwar, Uttarakhand, India
Altus Hygienic Products Private Limited₹1.07 Cr (FY 2023)-47.0%Kheda, Gujarat, India
Cimsons Scientific Syndicate Private Limited₹1.07 Cr (FY 2024)-14.0%Kottayam, Kerala, India
Stansys Life Sciences Private Limited₹1.07 Cr (FY 2025)-1.0%Gorakhpur, Uttar Pradesh, India

To see the full peer comparison of Pediakind Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pediakind Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Pediakind Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AANCP1308C1ZXMadhya PradeshActive02 Aug 2022

To see the full GST registrations and return filing status of Pediakind Pharma Private Limited, buy the company report.

Recent activity

Pediakind Pharma Private Limited has 5 board changes on record since 2023: 2 appointments and 3 cessations. The latest: Ankush Kumar Ekhe ceased to be Director on 09 Oct 2023.

AGM
Pediakind Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Pediakind Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Ankush Kumar Ekhe ceased to be Director.
Appointed
Rakesh Gaami was appointed as Additional Director.
Ceased
Gajendra Gami ceased to be Additional Director.
Appointed
Gajendra Gami was appointed as Director.
Ceased
Rakesh Gaami ceased to be Director.
Incorporation
02 Aug 2022
Pediakind Pharma Private Limited was registered on 02 Aug 2022 with Roc Ahmedabad & aged 4 years 3 months as per MCA records.

Frequently asked questions

Pediakind Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 August 2022 (4+ years old) and is registered under CIN U24230GJ2022PTC134435.

Pediakind Pharma has 2 current directors:

The latest financial statements of Pediakind Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Pediakind Pharma is 23AANCP1308C1ZX, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Pediakind Pharma is U24230GJ2022PTC134435. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pediakind Pharma was incorporated on 02 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Pediakind Pharma by revenue are Macwin Pharmaceuticals Private Limited, Alliswell Biohealth Private Limited, Agribee Seeds Private Limited, Ornate Pharma Pvt Ltd, Chemenz Labs (India) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ankush Kumar Ekhe ceased to be Director on 09 Oct 2023. Rakesh Gaami was appointed as Additional Director on 09 Oct 2023. Gajendra Gami ceased to be Additional Director on 24 Sep 2023. Pediakind Pharma has 5 board changes on record in total.

Yes, Pediakind Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0062166).

The registered office of Pediakind Pharma is at Flat 7 – G Ayodhya Nagar Opp – Sahjivan Society Shanti Nagar Usmanpura, Ahmedabad, Gujarat, India – 380013.

Pediakind Pharma operates in the pharma industry, in the drug formulation and development segment.